Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LGND compared with SUPN: revenue, margins and what each company keeps, and the suppliers and customers both name
LGND
Ligand Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
SUPN
Supernus Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LGND
Ligand Pharmaceuticals Inc
vs
SUPN
Supernus Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LGND, solid
SUPN, dashed
LGND
Ligand Pharmaceuticals Inc
Change
306.27
▲
+2.43%
· post 308.00
Mkt cap
$6.1B
Revenue
$79M
Q3 FY26
Revenue
$268M
FY25
SUPN
Supernus Pharmaceuticals, Inc.
Change
26.15
▼
−2.21%
· post 26.15
Closed
Nov 6 '26
Mkt cap
$3.1B
Revenue
$356M
Q3 FY26
Revenue
$719M
FY25
vs
Compare
Closed
Nov 6 '26
LGND
Ligand Pharmaceuticals Inc
vs
SUPN
Supernus Pharmaceuticals, Inc.
306.27
▲
+2.43%
post 308.00
Price
26.15
▼
−2.21%
post 26.15
$6.1B
Mkt cap
$3.1B
Q3 FY26
$79M
Revenue
$356M
Q3 FY26
FY25
$268M
Revenue
$719M
FY25
Change
Change
LGND
306.27
▲
+2.43%
vs
SUPN
26.15
▼
−2.21%
Closed
Nov 6 '26